Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Chuck Campbell who wrote (1858)	3/1/1999 7:12:00 PM
From: j_fir2	Read Replies (1) \| Respond to of 10280

Overstepped your bounds?!! What are you talking about? Welcome to the forum, please stick around--and speak up! Those bonds of SEPR and their rating--any comments from the analysts?

To: Chuck Campbell who wrote (1858)	3/1/1999 10:30:00 PM
From: Neuroguy	Read Replies (1) \| Respond to of 10280

Chuck - thanks for the clarification. I have an unwholesome habit of calling SEPR a 'biotech' in posts, which it is most assuredly not! I'm not really sure what you would call it - not so much a chemistry based pharmaceutical as a patent based one. Afterall, the chemistry & pharmacology of the isomers was a matter of record; all SEPR did was develop the proper separation technology and then scoop up the patents. Regardless of definition, they had a great idea and went with it. Kudos. And nice summary of SEPR. Neurodude